HI
ADCT icon

Harbour Investments’s ADC Therapeutics ADCT Stock Holding History

Harbour Investments’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75 Hold
20
– – ﹤0.01% 4537
2025
Q4 		$71 Hold
20
– – ﹤0.01% 3765
2025
Q3 		$80 Hold
20
– – ﹤0.01% 3657
2025
Q2 		$54 Hold
20
– – ﹤0.01% 3545
2025
Q1 		$28 Hold
20
– – ﹤0.01% 3514
2024
Q4 		$40 Hold
20
– – ﹤0.01% 3442
2024
Q3 		$63 Hold
20
– – ﹤0.01% 3338
2024
Q2 		$63 Buy
+20
New +$79 ﹤0.01% 3228

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Harbour Investments's ADCT Position: Q1 2026 in Review

Harbour Investments held its ADC Therapeutics (ADCT) position steady in Q1 2026 at 20 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #4537.

Harbour Investments first reported a position in ADCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $80 in Q3 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Harbour Investments held 20 shares of ADC Therapeutics worth $75 as of Q1 2026.
  • Harbour Investments left its ADC Therapeutics share count unchanged in Q1 2026.
  • ADC Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4537 holding.
  • Harbour Investments first reported a position in ADC Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Harbour Investments's ADC Therapeutics position peaked at $80 in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.